This was evidenced in the current work where the enhanced expression of Ki-67 in the brain induced by LPS was significantly combatted with the administration of each of dapagliflozin or hesperidin which signifies their role as cell cycle modulators in amelioration of the pathogenic events of AD. Here, MKI67 is linked to Alzheimer disease.